There is no question that cardiovascular diseases (CVDs) are a top priority for scientists and healthcare experts. According to the World Health Organization (WHO), CVDs are the leading cause of death globally , with 17.9 million people dying every year. The most common CVDs include coronary heart
There is no question that a cancer diagnosis has long inspired dread among both patients and doctors. Depending on the type and severity of the disease, cancer can be challenging to diagnose and treat, and the medical community is still working on better understanding the disease and how to manage
The last few years have been challenging for scientists, researchers, and doctors around the world. As the COVID-19 pandemic spread everywhere and an increasing number of people contracted the virus, the development of new vaccines, treatments, and drugs became crucial. Biopharmaceutical companies
The pharmaceutical sector is highly capital-intensive and competitive, with new technologies and innovations being developed all the time. As the industry transitions to the digital age, emerging inventions are transforming the way drugs are developed, tested, and marketed. These technologies
The COVID-19 pandemic has taught scientists, policymakers, and individuals around the world many lessons about the future of both healthcare systems and the biopharmaceutical industry. Moreover, this new virus and the disease it caused has also prompted numerous companies operating in these fields
Gene therapy is a medical field that focuses on developing personalized treatments that have the potential to save or change lives by inactivating a defective gene or replacing it with a functional one. As AI has already proven its ability to impact healthcare positively , this emerging technology
